Results 181 to 190 of about 79,826 (246)

Single catheter strategy for transradial angiography and primary percutaneous coronary intervention enhances procedural efficiency, microvascular outcomes, and cost-effectiveness: Implications for STEMI healthcare in resource-limited settings. [PDF]

PLoS One
Arneja M, Gunasekar S, Narayanan DH, Joseph J, Kovvuri H, Shanmugam S, Kumar PS, Anandaram A, Balakrishnan VK, Balasubramaniyan JV, Shanmugasundaram S, Ramesh S, Senguttuvan NB.   +12 more
europepmc   +1 more source

Prenylcysteine Oxidase 1 Deficiency Protects the Cardiac Muscle Cell Line HL‐1 Against Ischaemic/Hypoxic Stress

The FASEB Journal, Volume 40, Issue 8, 30 April 2026.
Ischaemic/hypoxic stress leads to heart remodeling and dysfunction. PCYOX1 promotes cardiomyocyte survival during injury, reducing the generation of reactive oxygen species. PCYOX1 deficiency regulates key proteins to preserve cardiomyocyte structure and function such as creatine kinase.
Cristina Banfi, Lisa Brocca, Alice Bascucci, Giulia Giusy Papaianni, Alice Mallia, Sonia Eligini   +5 more
wiley   +1 more source

Comparative Benefits of Primary Percutaneous Coronary Intervention Versus Onsite Fibrinolytic for Patients With ST-Segment-Elevation Myocardial Infarction: A Quasi-Experimental Study. [PDF]

J Am Heart Assoc
Zhou S, Xie S, You B, Xiang D, Fang W, Trisolini MG, Labresh KA, Smith SC, Zheng ZJ, Jin Y, Liu F, Huo Y.   +11 more
europepmc   +1 more source

Cardiac magnetic resonance assessment of long-term cardiac function after early recombinant staphylokinase thrombolysis before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction patients. [PDF]

Quant Imaging Med Surg
Gong H, Wang Y, Li C, Yin J, Chen P, Wang J, Zhou Y, Zhu X, Li C, Xu Y.   +9 more
europepmc   +1 more source

Prophylactic Beta-Blocker Therapy in Patients Who Underwent Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Affas Z, Patel K, Abuzahrieh OR, Al Barznji S, Walji M, Touza R, Albanna M, Zughaib M.   +7 more
europepmc   +1 more source

Prognostic Value of Myocardial Blush Grade in Patients With ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Primary Percutaneous Coronary Intervention (PCI): Association With Reperfusion Success and In-Hospital Outcomes. [PDF]

Cureus
Khan SW, Ahtesham M, Azim FE, Sajid M, Fayyaz A, Ullah I, Khan Z.   +6 more
europepmc   +1 more source

Pharmaco-Invasive Strategy with Half-Dose Recombinant Human Prourokinase Versus Primary Percutaneous Coronary Intervention. [PDF]

Anatol J Cardiol
Jiang C, Dou J, Yang H, Guo R, Gao J, Liu B, Shu H, Hou Y, Zhao L, Guo J, Luo D.   +10 more
europepmc   +1 more source

Evaluation of evolocumab on saphenous vein graft patency following coronary artery bypass graft surgery in people living with and without diabetes in the NEWTON‐CABG CardioLink‐5 trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4376-4381, May 2026.
Hwee Teoh, Subodh Verma, G. B. John Mancini, Adrian Quan, Michael Szarek, Randi Elituv, Meena Verma, Elizabeth Misner, Aishwarya Krishnaraj, Peter Jüni, Michael J. Koren, Stephen J. Nicholls, Deepak L. Bhatt, C. David Mazer, Lawrence A. Leiter   +14 more
wiley   +1 more source

Associated factors of spontaneous reperfusion in patients with acute ST-segment elevation myocardial infarction before primary percutaneous coronary intervention. [PDF]

Afr Health Sci
He W, Lin Y, Yuan F, Zhang T.
europepmc   +1 more source

Microcirculatory Resistance After Primary Percutaneous Coronary Intervention Predicts Residual Myocardial Damage and Scar Formation. [PDF]

J Am Heart Assoc
Candreva A, Gotschy A, Stehli J, Bissig L, Lodi Rizzini M, Chiastra C, Gallo D, Morbiducci U, Klingenberg R, Heg D, Matter CM, Ruschitzka F, Manka R, Stähli BE.   +13 more
europepmc   +1 more source